-
Under the trend of innovation, the pharmaceutical industry has set off a wave of cooperation
Time of Update: 2021-11-15
On October 22, Genetron Health, which focuses on providing tumor molecular detection, cancer early screening and companion diagnostic development services, announced that it has entered into an agreement with Jiangsu Fosun Pharmaceutical Sales Co.
-
The large-scale price increase of Chinese medicinal materials in this area has made it an industry consensus to improve forecasting and control capabilities
Time of Update: 2021-11-15
Under the background that the price increase of Chinese medicinal materials will be a long-term trend, the industry generally believes that Chinese medicine companies need to strengthen the monitoring of market prices to improve their control and forecasting capabilities of market conditions .
-
Full release of Chinese medicine formula granules (part 1)
Time of Update: 2021-11-15
From now on, the trial of traditional Chinese medicine formula granules has officially ended . From November 1st, the 27-year-long trial of traditional Chinese medicine formula granules has been comp
-
FDA blockbuster drug approval plan in November 2021
Time of Update: 2021-11-15
It is worth mentioning that Tavneos is the first oral complement 5a receptor (C5aR) inhibitor approved by the US FDA and the first drug approved for the treatment of ANCA-related vasculitis in ten years .
-
"Going Global" embraces a broader market, and pharmaceutical companies have made new progress in their internationalization
Time of Update: 2021-11-15
In recent years, China's pharmaceutical industry has ushered in a golden period of development, and companies have begun to "go global" and participate in international competition .
-
Liaoning issued a document: 169 drugs were "stopped" procurement without review
Time of Update: 2021-11-15
According to the research of relevant securities companies, the national sales of iohexol injection will be about 4 billion yuan in 2020; another example is the new generation of proton pump inhibitor (PPI) esomeprazole sodium.
-
The 100 billion industry chain grows up!
Time of Update: 2021-11-15
Xiamen Biopharmaceutical listed companies collectively rose in the first three quarters Previous post: Hainan issued 14 "Drug Production Licenses" (B Certificates), injecting new vitality into the development of medicine [Information Search] [Add to Favorites] [Tell a Friend] [Print This Article] [Close Window] A total of 0 similar information [View all] Related comments com/static/api/js/share.
-
Pharmacists in pharmacies can be evaluated
Time of Update: 2021-11-15
3. Obtain a bachelor's degree in pharmacy, Chinese pharmacy or related majors or graduate from the preparatory technician (technician) class of technical colleges and universities, obtain the title of pharmacist (Chinese pharmacist), and have been employed for more than 4 years .
-
The resignation storm in the pharmaceutical industry is intensifying, and a group of company general managers and presidents resign
Time of Update: 2021-11-15
Kangyuan Pharmaceutical also issued an executive change announcement in October stating that the company’s board of directors recently received a resignation report from Director, Deputy General Manager, Board Secretary and Chief Financial Officer Yin Honggang.
-
Traditional Chinese medicine is showing a vigorous trend of old trees and new shoots, and the multi-faceted layout of pharmaceutical companies ushered in new growth
Time of Update: 2021-11-15
2 billion yuan; the total net profit attributable to shareholders of listed companies has increased year-on-year.
In recent years, the country has continued to promote the development of the Chinese medicine industry with favorable policies .
-
Pharmacy sales of four types of drugs require nucleic acid certification within 48 hours
Time of Update: 2021-11-15
In addition to requiring customers to provide nucleic acid negative certificates, pharmacies must also register detailed drug purchase information, including: name, gender, age, personal ID number, home address, body temperature, mobile phone number, and specific origin (local, returning from abroad) , The name, quantity, date of purchase and other information of the purchased drug .
-
The scale of the biopharmaceutical market continues to expand, and the demand for related equipment continues to grow
Time of Update: 2021-11-15
Therefore, in this context, the industry believes that while domestic pharmaceutical equipment companies see opportunities, they also need to continuously increase R&D investment to accelerate the breaking of import monopoly, realize the substitution of imported products, and help China's biopharmaceutical industry to become more Good development .
-
Junshi Bio-Treplimumab's application for a biological product license for the treatment of nasopharyngeal carcinoma was accepted by the FDA
Time of Update: 2021-11-15
In February 2021, the marketing application for new indications for the first-line treatment of locally recurring or metastatic nasopharyngeal carcinoma patients with teriprizumab combined with cisplatin and gemcitabine was accepted by the State Food and Drug Administration .
-
Anhui Province will collect 45 unreviewed drugs, which may trigger a wave of price cuts
Time of Update: 2021-11-15
It is understood that Beijing Sunshine Purchasing Network recently issued a "Notice on Suspending the Purchasing Function of Some Products That Have Not Passed the Consistency Evaluation in the Scope of Centralized National Procurement.
-
After investing huge sums of money, some pharmaceutical companies began to experience "dyspepsia"
Time of Update: 2021-11-15
In fact, due to the difficulty, time-consuming, labor-intensive, and costly research and development of new drugs, many pharmaceutical companies have been vigorously making new investment arrangements in order to increase corporate operating profits in recent years .
-
MVC-COV1901, a high-end vaccine, was selected for the WHO New Coronary Pneumonia Solidarity Test Vaccine
Time of Update: 2021-11-15
Taipei, October 28, 2021/PRNewswire/ - The vaccine candidate MVC-COV1901 of Medigen Vaccine Biologics Corp ("High-end Vaccine") was recommended by an independent vaccine priority advisory group to be included in the world The Solidarity Vaccine Trial (STv) of the World Health Organization (WHO) .
-
my country's vaccine market is about to exceed 60 billion yuan, and more requirements will be placed on this industry
Time of Update: 2021-11-15
There are still a few domestic companies that can provide high-end vaccine manufacturing and filling equipment; therefore, in order to further ensure vaccine safety and Production capacity, local pharmaceutical equipment companies must continue to innovate, improve production efficiency through continuous improvement of product technology, intelligence, and automation, and ensure the safety and control of product quality in vaccine production and storage .
-
40% of 390,000 medical insurance pharmacies will be transformed
Time of Update: 2021-11-15
Before the end of next month, there must be "dual channel" pharmacies everywhereBefore the end of next month, there must be "dual channel" pharmacies everywhereIn accordance with the requirements of the National Medical Insurance Administration, in principle, by the end of October 2021, each province shall determine the list of drugs that are included in the “dual-channel” management of the province and announce it to the public .
-
In the first nine months, the number of new stores in the four major domestic drugstores exceeded 1,000!
Time of Update: 2021-11-15
During the reporting period, the company built 1,300 new stores, closed 26 stores due to urban transformation and strategic location adjustments, relocated 123 stores, net added 1,151 stores, and directly-operated chain stores reached 8,356 .
-
PDC drugs set off a fever for research and development, and large pharmaceutical companies are competing for layout
Time of Update: 2021-11-15
Currently, there are two PDC drugs on the market worldwide, one of which is Lutathera developed by Advanced Accelerator Applications SA, a subsidiary of Novartis, and is the world's first peptide receptor radionuclide therapy (PRRT) drug .
